Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.49
-0.05 (-0.59%)
At close: Dec 20, 2024, 4:00 PM
8.40
-0.09 (-1.06%)
After-hours: Dec 20, 2024, 4:34 PM EST
Zevra Therapeutics Employees
As of December 31, 2023, Zevra Therapeutics had 69 total employees, including 65 full-time and 4 part-time employees. The number of employees increased by 33 or 91.67% compared to the previous year.
Employees
69
Change (1Y)
33
Growth (1Y)
91.67%
Revenue / Employee
$354,913
Profits / Employee
-$1,299,478
Market Cap
453.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
DocGo | 4,164 |
InnovAge Holding | 2,350 |
Ginkgo Bioworks Holdings | 1,218 |
MeiraGTx Holdings | 425 |
UroGen Pharma | 201 |
Humacyte | 185 |
AnaptysBio | 117 |
Kodiak Sciences | 111 |
ZVRA News
- 4 days ago - Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024 - GlobeNewsWire
- 15 days ago - Zevra Therapeutics Announces Organizational Changes - GlobeNewsWire
- 25 days ago - Zevra Therapeutics to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C - GlobeNewsWire
- 5 weeks ago - Zevra Therapeutics, Inc. (ZVRA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting - GlobeNewsWire
- 6 weeks ago - Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13 - GlobeNewsWire
- 7 weeks ago - Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024 - GlobeNewsWire